129 related articles for article (PubMed ID: 16374117)
21. Masking effect of chronic pancreatitis in the interpretation of somatostatin receptor positron emission tomography in pancreatic neuroendocrine tumors.
Treglia G; Farchione A; Stefanelli A; Brizi MG; Larghi A; Inzani F; Rindi G; Rufini V
Pancreas; 2013 May; 42(4):726-8. PubMed ID: 23591437
[No Abstract] [Full Text] [Related]
22. [Neuroendocrine lung tumor with liver metastases and carcinoid syndrome].
Argibay Vázquez S; Núñez Cambre I; Luna Vega V; Ruibal Morell A
Med Clin (Barc); 2007 Mar; 128(11):440. PubMed ID: 17394864
[No Abstract] [Full Text] [Related]
23. Management of pancreatic endocrine tumors in patients with multiple endocrine neoplasia type 1.
Thompson NW
Surg Oncol Clin N Am; 1998 Oct; 7(4):881-91. PubMed ID: 9735139
[TBL] [Abstract][Full Text] [Related]
24. Initial direct comparison of 99mTc-TOC and 99mTc-TATE in identifying sites of disease in patients with proven GEP NETs.
Cwikla JB; Mikolajczak R; Pawlak D; Buscombe JR; Nasierowska-Guttmejer A; Bator A; Maecke HR; Walecki J
J Nucl Med; 2008 Jul; 49(7):1060-5. PubMed ID: 18552141
[TBL] [Abstract][Full Text] [Related]
25. Metastasis of neuroendocrine colon carcinoma mimicking Graves' ophthalmopathy.
Busse F; Führer D; Stumvoll M; Schneider JP; Neid M; Kluge R; Sterker I
Thyroid; 2008 Nov; 18(11):1237-8. PubMed ID: 18925841
[No Abstract] [Full Text] [Related]
26. Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors.
Schillaci O; Spanu A; Scopinaro F; Falchi A; Danieli R; Marongiu P; Pisu N; Madeddu G; Delle Fave G; Madeddu G
J Nucl Med; 2003 Mar; 44(3):359-68. PubMed ID: 12621001
[TBL] [Abstract][Full Text] [Related]
27. Influence of isotope dose on somatostatin receptor imaging: when less is better.
Schirmer TP; O'Dorisio TM; Olsen JO; Hinkle GH; O'Dorisio MS; Schirmer WJ
Semin Oncol; 1994 Oct; 21(5 Suppl 13):51-5. PubMed ID: 7992082
[No Abstract] [Full Text] [Related]
28. Intraoperative detection of somatostatin-receptor-positive neuroendocrine tumours using indium-111-labelled DTPA-D-Phe1-octreotide.
Wangberg B; Forssell-Aronsson E; Tisell LE; Nilsson O; Fjalling M; Ahlman H
Br J Cancer; 1996 Mar; 73(6):770-5. PubMed ID: 8611378
[TBL] [Abstract][Full Text] [Related]
29. [The scintigraphy of somatostatin receptors in the carcinoid tumor].
Banzo J; Abós MD; Prats E; Delgado M; Razola P; García S; Gomollón F; García F
Rev Esp Med Nucl; 2001 Feb; 20(1):11-8. PubMed ID: 11181324
[TBL] [Abstract][Full Text] [Related]
30. [Somatostatin receptor scintigraphy in medullary thyroid carcinomas, GEP and carcinoid tumors].
Eising EG; Farahati J; Bier D; Knust EJ; Reiners C
Nuklearmedizin; 1995 Feb; 34(1):1-7. PubMed ID: 7724358
[TBL] [Abstract][Full Text] [Related]
31. Increased uptake of (131)I-MIBG after intra-arterial application in liver metastases of a neuroendocrine tumor.
Popp M; Strumpf A; Zöphel K; Stroszczynski C; Kotzerke J
Eur J Nucl Med Mol Imaging; 2010 Jan; 37(1):180. PubMed ID: 19789869
[No Abstract] [Full Text] [Related]
32. Radiotherapy with a radiolabeled somatostatin analogue, [111In-DTPA-D-Phe1]-octreotide. A case history.
Krenning EP; Kooij PP; Bakker WH; Breeman WA; Postema PT; Kwekkeboom DJ; Oei HY; de Jong M; Visser TJ; Reijs AE
Ann N Y Acad Sci; 1994 Sep; 733():496-506. PubMed ID: 7978900
[No Abstract] [Full Text] [Related]
33. Contrast-enhanced low mechanical index endoscopic ultrasound (CELMI-EUS).
Dietrich CF
Endoscopy; 2009; 41 Suppl 2():E43-4. PubMed ID: 19288418
[No Abstract] [Full Text] [Related]
34. [Pre- and intraoperative localization of neuroendocrine tumors].
Adams S; Baum RP; Adams M; Wenisch H; Schumm-Draeger PM; Encke A; Usadel KH; Hör G
Acta Med Austriaca; 1997; 24(2):81-6. PubMed ID: 9273812
[TBL] [Abstract][Full Text] [Related]
35. [Detection of intrathoracic infectious lesions using In-diethylenetriamine pentaacetic bicyclic anhydride-IgG (111In-DTPA-IgG) scintigraphy].
Ota T; Goto H; Wada H; Yuasa K; Iguchi M; Okamura T; Ieki R; Suzuki K
Kansenshogaku Zasshi; 1998 Feb; 72(2):128-35. PubMed ID: 9545688
[TBL] [Abstract][Full Text] [Related]
36. [A case of metastatic gastrinomas in the liver visualized by 111In-DTPA-D-Phe-octreotide (111In-pentetreotide)].
Tani A; Nakabeppu Y; Tsuchimochi S; Nakajo M; Yoshinaga T; Kiku T
Kaku Igaku; 1996 May; 33(5):545-9. PubMed ID: 8699623
[TBL] [Abstract][Full Text] [Related]
37. Chronic hypersensitivity pneumonitis with heart involvement observed during in-111 DTPA octreotide (OctreoScan) imaging.
Zanglis A; Andreopoulos D; Zissimopoulos A; Baziotis N
Clin Nucl Med; 2003 Dec; 28(12):994-5. PubMed ID: 14663328
[No Abstract] [Full Text] [Related]
38. [Neuroendocrine carcinoma].
Kacl GM; Schubiger C; Eriksson U
Schweiz Med Wochenschr; 1998 Nov; 128(48):1915. PubMed ID: 9879621
[No Abstract] [Full Text] [Related]
39. [Parascapular lipoma with expression of somatostatin receptors detected by (99m)Tc-EDDA/HYNIC-TOC scintigraphy].
Mendoza Narváez JA; Bellón Guardia ME; García Vicente AM; Palomar Muñoz A; Talavera Rubio MP; Soriano Castrejón AM
Rev Esp Med Nucl Imagen Mol; 2012; 31(4):225-6. PubMed ID: 23067692
[No Abstract] [Full Text] [Related]
40. Diffuse Bone Metastases in Pancreatic Neuroendocrine Tumor Shown on Octreoscan.
Adkins J; Lu Y
Clin Nucl Med; 2019 Mar; 44(3):257-258. PubMed ID: 30624276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
